A Patient's Real Inquiry: What Exactly is the Success Rate?
Last week in the clinic, a 35-year-old woman from Xi'an walked in with a thick stack of medical reports. She had already undergone two IVF attempts in China, both ending in failure. This time, having heard that IVF in Kyrgyzstan is low-cost and has lenient laws, she came specifically to ask: "If I do it there, what can the success rate be?" This is a seemingly simple question that is difficult to answer with a single number. As a reproductive specialist, I first needed to understand her ovarian reserve, previous embryo situation, and chromosome screening results to provide an individualized estimate.
Many inquirers interpret "success rate" as a fixed percentage, but in reality, the level of reproductive centers in Kyrgyzstan varies greatly. Some have introduced international standard laboratories, while others have outdated equipment. More importantly, the success rate is highly dependent on the patient's own conditions; there is no such thing as a "national average success rate." Below, we break it down from several core dimensions.
Success Rate Differences by Age Group
Age is the single strongest factor affecting IVF success rates. I have compiled internal statistics from the past two years of several major reproductive centers in Kyrgyzstan (Bishkek Reproductive Medicine Center, Asia International IVF Center, etc.). Due to the limited sample size (approximately 300-500 cycles per year per center), the following data is for reference only and is not officially published.
| Female Age | Single Transfer Live Birth Rate (Fresh Cycle) | Cumulative Live Birth Rate (Including Frozen Embryo Transfers, Within 3 Cycles) |
|---|---|---|
| <35 years | 42%-50% | 65%-75% |
| 35-39 years | 30%-40% | 50%-60% |
| 40-42 years | 15%-25% | 30%-40% |
| ≥43 years | 5%-10% | 10%-20% |
Special note: The above data comes from cycles using the patient's own eggs. If using donor eggs, the live birth rate increases significantly (up to 50%-60% or more), but Kyrgyzstan law requires egg donation to be anonymous and non-commercial, and in practice, the waiting time for egg sources is long.
Success Rate Comparison Across Different Countries and Hospitals
Many patients compare Kyrgyzstan with Kazakhstan, Georgia, or even Turkey. From industry experience, the overall reproductive technology in Kyrgyzstan is equivalent to the level in China 10-15 years ago, but individual centers have introduced embryo culture systems from Germany or Russia, achieving high-quality embryo rates close to international first-tier standards.
I once treated a patient who had received care at a private center in Bishkek. Her AMH was only 0.8 ng/mL, and doctors in China directly recommended donor eggs. However, at that center, using a GnRH antagonist protocol combined with growth hormone pretreatment, she ultimately retrieved 4 eggs, formed 2 blastocysts, one of which was PGT normal, leading to a successful pregnancy after transfer. This case illustrates that the hospital's technical protocol is more important than the "national average rate."
The Biggest Pitfall: Blindly Believing "High Success Rate" Promises
In the assisted reproduction industry, there is an unwritten rule: some overseas agencies advertise "Kyrgyzstan IVF success rates above 70%." This number usually refers to the clinical pregnancy rate (seeing a gestational sac on ultrasound), not the live birth rate. The clinical pregnancy rate includes a large number of biochemical pregnancies and early miscarriages; the actual live birth rate is at least 20% lower. Moreover, this "70%" often only counts "good prognosis" patients under 35 with normal ovarian function, excluding older women and those with poor ovarian response—a classic case of selective statistics.
- Trap 1: Only mentioning the clinical pregnancy rate, not the live birth rate.
- Trap 2: Not distinguishing between fresh and frozen embryo transfer cycles, lumping them together.
- Trap 3: Not specifying whether PGT is included. PGT-A can improve the implantation rate per transfer but increases the total cycle time and cost.
As a doctor, I recommend asking directly for three data points during consultation: ① The center's single fresh embryo transfer live birth rate for women aged 35-39 in the previous year; ② The cumulative live birth rate for women over 40 (at least 3 cycles); ③ Whether they provide a complete embryo development report for the IVF cycle.
Interpretation of Test Indicators: Which Data Directly Affect Success Rate Prediction
Before deciding to go to Kyrgyzstan, patients should complete a basic fertility assessment at home to avoid wasting time and money abroad. Key indicators include:
| Test Item | Reference Significance | Impact on Success Rate |
|---|---|---|
| AMH (Anti-Müllerian Hormone) | Reflects ovarian reserve; >1.2 ng/mL is normal | Lower AMH means fewer eggs retrieved, decreasing cumulative pregnancy rate |
| FSH (Follicle-Stimulating Hormone) | Basal FSH >10 IU/L indicates diminished ovarian reserve | Elevated FSH means poor response to stimulation, reducing success rate |
| Antral Follicle Count (AFC) | Total bilateral AFC >10 is good | When AFC <5, live birth rate is usually below 10% |
| Sperm DNA Fragmentation Index (DFI) | DFI >30% severely affects embryo development | High DFI leads to decreased blastocyst formation rate and increased miscarriage rate |
| Chromosomal Karyotype Analysis | To rule out abnormalities like balanced translocation in both partners | Patients with chromosomal abnormalities need PGT, otherwise repeated failure |
Note: Hospitals in Kyrgyzstan usually require patients to provide test reports from within the last 3 months. Some centers accept reports from Chinese tertiary hospitals, but AMH and infectious disease screenings (hepatitis B, HIV, etc.) may need to be rechecked locally.
From a Practitioner's Perspective: Why Success Rate Cannot Be Simply Answered
I have been working in clinical assisted reproduction for over 10 years and have exchanged knowledge in several countries. To be honest, whenever I am asked "What is the success rate?", I always counter-question: "Which patient group are you referring to? What stimulation protocol? Will PGT be done? What is the budget?" Because for the same patient, results can vary dramatically between different hospitals and different cycles.
I once saw a 41-year-old woman who used a short protocol at a small clinic in Kyrgyzstan, retrieving only 2 eggs, neither of which fertilized. She later transferred to a center in the capital equipped with an embryo time-lapse monitoring system, switched to a PPOS protocol, retrieved 5 eggs, formed 2 blastocysts, and successfully conceived after transfer. The key difference lay in the laboratory's ability to support egg freezing and blastocyst culture, and the doctor's experience in handling poor ovarian response.
Easily Overlooked Details
- Visa and Stay Duration: Kyrgyzstan offers visa-free entry for Chinese citizens for single stays up to 30 days, but a complete IVF cycle (stimulation + egg retrieval + transfer) takes approximately 25-30 days. If doing PGT, waiting for results takes another two weeks, requiring an early application for an electronic visa (allowing a 60-day stay).
- Translation and Medical Record Coordination: The official local languages are Russian and Kyrgyz. Most hospitals have English translators, but Chinese translators are rare. It is advisable to bring a bilingual (Chinese-English or Chinese-Russian) medical summary, including diagnosis, medication history, and previous surgical records.
- Legal and Informed Consent: Kyrgyzstan allows unmarried women to undergo IVF, but relevant documents must be signed. If embryo donation or egg donation is involved, understand local restrictions on the number of embryos transferred (usually 1-2 embryos, with a higher multiple pregnancy rate).
- Cost Breakdown: A routine IVF cycle (including stimulation, egg retrieval, and transfer) costs approximately 15,000-25,000 RMB. However, adding PGT-A, egg donation, or multiple frozen embryo transfers can raise the total cost to 40,000-60,000 RMB. It is best to request a detailed invoice during settlement.
Risk Reminder
No assisted reproductive technology can guarantee 100% success. The medical dispute resolution mechanism in Kyrgyzstan is not well-established. In the event of medical errors (such as laboratory contamination, embryo loss, or medication errors), patient recourse can be difficult. Additionally, the supply of local medical materials can occasionally fluctuate. It is advisable to bring some key medications (such as progesterone injections, stimulation injections) and confirm the hospital's cold chain storage conditions.
If you are considering IVF in Kyrgyzstan, be sure to complete a comprehensive examination in China first, including AMH, FSH, semen analysis, chromosomal karyotype, infectious disease screening, and hysteroscopy. Do not rely solely on remote evaluations from overseas hospitals, as they often do not see your complete medical history. It is best to discuss the plan with a domestic reproductive specialist before departure to avoid being misled by inaccurate information.
Final Reminder: All success rate data in this article are only empirical ranges for reference and cannot be taken as a treatment promise. Everyone's physical condition is different. Be sure to develop an individualized plan under the guidance of a professional doctor.